Sponsor pipeline

Tolmar Inc. clinical trial pipeline

Get alerts when Tolmar Inc.'s trials change

3 active trials 0 recruiting 2 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-09-02
Primary completion pushed: 2028-06 → 2030-03
Completion pushed: 2028-06 → 2030-03
NCT05645536 Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have… · Phase 3

Active trials by phase

Phase 3
2
Phase 4
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06385509 A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for… Hypogonadism Active, Not Recruiting 2025-09-04
Phase 3
NCT05645536 Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have… Breast Cancer Enrolling by Invitation 2026-09-01
NCT04906395 Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer Breast Cancer Active, Not Recruiting 2026-01-13

Disease areas by active trials

Breast Cancer (2)

Get alerts when Tolmar Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free